Herpetic whitlow and dyshidrotic eczema are relatively common rashes that can have a similar appearance. But they have different causes, symptoms, and treatments. Your hands are one of the most ...

Dyshidrotic eczema, also called pompholyx, is a type of dermatitis that causes small blisters on your hands or feet. In most cases, this type of eczema begins between the ages of 20 and 40.

Egan and colleagues described five patients who had dyshidrotic eczema unresponsive to conventional ... variety of ways in the treatment of chronic hand dermatitis. Recently, UVA-1 has shown ...

3. Dyshidrotic eczema Dyshidrotic eczema causes small, itchy blisters on the hands and feet, often flaring during stress or temperature changes. Treatment may involve medicated soaks and ...

Dyshidrotic eczema Usually occurs in adults. Those who come into contact with heavy metals may be more prone to developing it. Typically hands and/or feet. Itchy, fluid-filled blisters may develop ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

Medically reviewed by Jurairat J. Molina, MDMedically reviewed by Jurairat J. Molina, MD Birth control, especially ...

Eczema is a group of conditions that make your skin inflamed or irritated. The most common type is atopic dermatitis. Conditions That Can Look Like Eczema but Aren’t Your dermatologist or ...

Eczema, a prevalent skin condition affecting millions worldwide, is characterized by dry, itching, and inflamed skin, frequently appearing on hands. Incorrect use of hand soap can exacerbate ...

Over the last 25 years, UConn great Diana Taurasi has been a star on the basketball court while living with the skin condition eczema.

Mr. Brann, who still copes with the debilitating rashes, is one of millions of people with eczema, a broad term for a group of skin conditions that affects about 10 percent of the U.S. population.

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...